Sinphar Pharmaceutical Co.,Ltd. (1734.TW)

TWD 29.1

(0.0%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 6.25 Billion 6.18 Billion 6.22 Billion 6.12 Billion 5.91 Billion 5.87 Billion
Total Current Assets 2.64 Billion 2.77 Billion 2.7 Billion 2.53 Billion 2.26 Billion 2.12 Billion
Cash And Short Term Investments 1.08 Billion 1.24 Billion 1.24 Billion 1.19 Billion 886.12 Million 975.13 Million
Cash and Cash Equivalents 1.07 Billion 1.23 Billion 1.19 Billion 1.14 Billion 840.71 Million 958.52 Million
Short Term Investments 6.66 Million 6.66 Million 50.1 Million 50.43 Million 45.4 Million 16.61 Million
Net Receivables 722.51 Million 792.36 Million 751.04 Million 659.91 Million 804.79 Million 656.47 Million
Inventory 839.19 Million 737.01 Million 697.39 Million 681.44 Million 567 Million 488.05 Million
Other Current Assets 5.74 Million 4.86 Million 10.03 Million 4.07 Million 4.08 Million 2.07 Million
Total Non-Current Assets 3.6 Billion 3.4 Billion 3.51 Billion 3.58 Billion 3.65 Billion 3.75 Billion
Net PPE 3.27 Billion 3.2 Billion 3.24 Billion 3.28 Billion 3.32 Billion 3.34 Billion
Good Will And Intangible Assets 71.82 Million 86.98 Million 117.29 Million 157.53 Million 190.35 Million 217.93 Million
Good Will - - - - - -
Intangible Assets 71.82 Million 86.98 Million 117.29 Million 157.53 Million 190.35 Million 217.93 Million
Long-Term Investments 15.55 Million 18.03 Million -29.74 Million -22.58 Million -15.01 Million 42.25 Million
Tax Assets 170.85 Million 52.1 Million 74.87 Million 51.86 Million 46.2 Million 35.69 Million
Other Non Current Assets 66.51 Million 45.23 Million 108.28 Million 113.15 Million 110.17 Million 113.85 Million
Other Assets - - - - - -
Total Liabilities 2.85 Billion 2.96 Billion 3.14 Billion 2.98 Billion 2.71 Billion 2.45 Billion
Total Current Liabilities 1.2 Billion 1.44 Billion 1.53 Billion 1.32 Billion 1.15 Billion 889.3 Million
Account Payables 291.2 Million 323.18 Million 201.26 Million 194.21 Million 209.99 Million 182.29 Million
Tax Payables 3.08 Million 45.4 Million 35.27 Million 34.18 Million 41.7 Million 21.8 Million
Short Term Debt 450.87 Million 497.89 Million 648.44 Million 552.74 Million 528.91 Million 337.9 Million
Deferred Revenue 425.24 Million 96.55 Million 648.92 Million 458.92 Million 388.01 Million 21.8 Million
Other Current Liabilities 37.36 Million 528.27 Million 35.86 Million 124 Million 28.87 Million 347.29 Million
Total Non Current Liabilities 1.64 Billion 1.52 Billion 1.6 Billion 1.65 Billion 1.55 Billion 1.56 Billion
Long-Term Debt 1.49 Billion 1.41 Billion 1.48 Billion 1.51 Billion 1.4 Billion 1.38 Billion
Deferred Revenue Non Current - - - - - -35.14 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 154.37 Million 106.81 Million 123.29 Million 142.96 Million 148.61 Million 184.36 Million
Other Liabilities - - - - - -
Total Equity 3.39 Billion 3.21 Billion 3.07 Billion 3.14 Billion 3.2 Billion 3.42 Billion
Stock Holders Equity 3.09 Billion 2.93 Billion 2.72 Billion 2.74 Billion 2.78 Billion 2.92 Billion
Common Stock 1.67 Billion 1.67 Billion 1.67 Billion 1.67 Billion 1.67 Billion 1.67 Billion
Retained Earnings 369.8 Million 233.72 Million -34.12 Million -31 Million 15.52 Million 59.23 Million
Accumulated other comprehensive income 318.42 Million 280.56 Million 306.88 Million 347.94 Million 321.99 Million 334.3 Million
Common Stock Equity 3.09 Billion 2.93 Billion 2.72 Billion 2.74 Billion 2.78 Billion 2.92 Billion
Capital Lease Obligation - - - 2.21 Million 5.96 Million 44.44 Million
Total Investments 22.21 Million 24.69 Million 20.35 Million 27.84 Million 30.38 Million 58.86 Million
Total Debt 1.94 Billion 1.91 Billion 2.13 Billion 2.06 Billion 1.93 Billion 1.71 Billion
Net Debt 870.53 Million 675.96 Million 939.61 Million 919.2 Million 1.09 Billion 761.01 Million

Balance Sheet Charts